These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11870113)

  • 21. The hormonal activity of the postmenopausal ovary.
    Vermeulen A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells.
    Rao ChV; Zhou XL; Lei ZM
    Biol Reprod; 2004 Aug; 71(2):579-87. PubMed ID: 15084485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testicular steroidogenesis in adult men with human chorionic gonadotropin-producing tumors.
    Rieu M; Reznik Y; Vannetzel JM; Mahoudeau J; Berrod JL; Kuhn JM
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2404-9. PubMed ID: 7629236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.
    Cheung AP; Pride SM; Yuen BH; Sy L
    Hum Reprod; 2002 Oct; 17(10):2540-7. PubMed ID: 12351525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The adrenal gland may be a target of LH action in postmenopausal women.
    Alevizaki M; Saltiki K; Mantzou E; Anastasiou E; Huhtaniemi I
    Eur J Endocrinol; 2006 Jun; 154(6):875-81. PubMed ID: 16728548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations of luteinizing hormone serum concentrations after exogenous human chorionic gonadotropin administration during ovarian hyperstimulation.
    Demoulin A; Dubois M; Gerday C; Gillain D; Lambotte R; Franchimont P
    Fertil Steril; 1991 Apr; 55(4):797-804. PubMed ID: 1901284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic studies on ovarian C-17,20-lyase activity: effect of luteinizing hormone surge.
    Eckstein B; Greenbaum O; Cohen S
    Endocrinology; 1985 Dec; 117(6):2376-82. PubMed ID: 4065036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
    Ibáñez L; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human chorionic gonadotrophin stimulation test as a predictor of ovarian response and pregnancy in IVF cycles stimulated with GnRH agonist gonadotrophin treatment: a pilot study.
    Fábregues F; Iraola A; Casamitjana R; Carmona F; Balasch J
    Hum Reprod; 2012 Apr; 27(4):1122-9. PubMed ID: 22313871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL; Barnes RB; Ehrmann DA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands.
    Nishii M; Nomura M; Sekine Y; Koike H; Matsui H; Shibata Y; Ito K; Oyama T; Suzuki K
    J Androl; 2012; 33(6):1233-8. PubMed ID: 22492843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
    Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
    Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats.
    Tungmahasuk D; Fungbun N; Laoharatchatathanin T; Terashima R; Kurusu S; Kawaminami M
    J Reprod Dev; 2018 Apr; 64(2):129-134. PubMed ID: 29249775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
    Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
    Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian and adrenal steroid production in the postmenopausal woman.
    Greenblatt RB; Colle ML; Mahesh VB
    Obstet Gynecol; 1976 Apr; 47(4):383-7. PubMed ID: 176614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.